Does ALPRAZOLAM Cause Hepatic cytolysis? 121 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 121 reports of Hepatic cytolysis have been filed in association with ALPRAZOLAM (Alprazolam). This represents 0.3% of all adverse event reports for ALPRAZOLAM.
121
Reports of Hepatic cytolysis with ALPRAZOLAM
0.3%
of all ALPRAZOLAM reports
3
Deaths
87
Hospitalizations
How Dangerous Is Hepatic cytolysis From ALPRAZOLAM?
Of the 121 reports, 3 (2.5%) resulted in death, 87 (71.9%) required hospitalization, and 19 (15.7%) were considered life-threatening.
Is Hepatic cytolysis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ALPRAZOLAM. However, 121 reports have been filed with the FAERS database.
What Other Side Effects Does ALPRAZOLAM Cause?
Drug abuse (8,827)
Toxicity to various agents (7,157)
Completed suicide (4,873)
Drug ineffective (4,040)
Overdose (2,967)
Drug dependence (2,743)
Somnolence (2,461)
Intentional overdose (2,389)
Death (2,317)
Suicide attempt (2,313)
What Other Drugs Cause Hepatic cytolysis?
ACETAMINOPHEN (1,469)
ATORVASTATIN (681)
PEMBROLIZUMAB (601)
CARBOPLATIN (577)
METHOTREXATE (468)
SULFAMETHOXAZOLE\TRIMETHOPRIM (356)
PACLITAXEL (324)
ENOXAPARIN (307)
AMOXICILLIN (273)
VALACYCLOVIR (261)
Which ALPRAZOLAM Alternatives Have Lower Hepatic cytolysis Risk?
ALPRAZOLAM vs ALPROSTADIL
ALPRAZOLAM vs ALTEPLASE
ALPRAZOLAM vs ALTERNARIA ALTERNATA
ALPRAZOLAM vs ALTHIAZIDE
ALPRAZOLAM vs ALTHIAZIDE\SPIRONOLACTONE